News on ICS from BioPortfolio.com http://www.BioPortfolio.com Consolidated ICS news from BioPortfolio.com Tue, 09 Feb 2010 20:20:33 GMT en Herbals Not the Answer for Asthma, Study Showshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036145&HITNO=0&MSIZE=107&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ICS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036145&THISHREF=http://c.moreover.com/click/here.pl%3fz2536508654%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036145&HITNO=0&MSIZE=107&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ICS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036145&THISHREF=http://c.moreover.com/click/here.pl%3fz2536508654%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedicineNet.com: Merck's asthma drug formoterol/mometasone to garner global peak year sales of more than $250Mhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034052&HITNO=1&MSIZE=107&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ICS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034052&THISHREF=http://c.moreover.com/click/here.pl%3fz2535582891%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034052&HITNO=1&MSIZE=107&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ICS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034052&THISHREF=http://c.moreover.com/click/here.pl%3fz2535582891%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Emerging Combination Agent From Merck Will Garner Peak Year Sales Of More Than $250M For The Treatment Of Asthmahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033728&HITNO=2&MSIZE=107&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ICS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033728&THISHREF=http://c.moreover.com/click/here.pl%3fz2535358216%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033728&HITNO=2&MSIZE=107&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ICS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033728&THISHREF=http://c.moreover.com/click/here.pl%3fz2535358216%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaceutical Online: Emerging Combination Agent from Merck Will Garner Peak Year Sales of More Than $250 Million for the Treatment of Asthmahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031325&HITNO=3&MSIZE=107&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ICS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031325&THISHREF=http://c.moreover.com/click/here.pl%3fz2534139657%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031325&HITNO=3&MSIZE=107&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ICS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031325&THISHREF=http://c.moreover.com/click/here.pl%3fz2534139657%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSt Louis Business Journal: Emerging Combination Agent from Merck Will Garner Peak Year Sales of More Than $250 Million for the Treatment of Asthmahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031298&HITNO=4&MSIZE=107&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ICS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031298&THISHREF=http://c.moreover.com/click/here.pl%3fz2534121597%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031298&HITNO=4&MSIZE=107&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ICS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031298&THISHREF=http://c.moreover.com/click/here.pl%3fz2534121597%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMemphis Business Journal: Emerging Combination Agent from Merck Will Garner Peak Year Sales of More Than $250 Million for the Treatment of Asthmahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031297&HITNO=5&MSIZE=107&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ICS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031297&THISHREF=http://c.moreover.com/click/here.pl%3fz2534121543%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031297&HITNO=5&MSIZE=107&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ICS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031297&THISHREF=http://c.moreover.com/click/here.pl%3fz2534121543%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTriad Business Journal: Emerging Combination Agent from Merck Will Garner Peak Year Sales of More Than $250 Million for the Treatment of Asthmahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031294&HITNO=6&MSIZE=107&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ICS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031294&THISHREF=http://c.moreover.com/click/here.pl%3fz2534120578%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031294&HITNO=6&MSIZE=107&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ICS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031294&THISHREF=http://c.moreover.com/click/here.pl%3fz2534120578%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPortland Business Journal: Emerging Combination Agent from Merck Will Garner Peak Year Sales of More Than $250 Million for the Treatment of Asthmahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031274&HITNO=7&MSIZE=107&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ICS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031274&THISHREF=http://c.moreover.com/click/here.pl%3fz2534115589%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031274&HITNO=7&MSIZE=107&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ICS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031274&THISHREF=http://c.moreover.com/click/here.pl%3fz2534115589%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comDayton Business Journal: Emerging Combination Agent from Merck Will Garner Peak Year Sales of More Than $250 Million for the Treatment of Asthmahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031273&HITNO=8&MSIZE=107&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ICS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031273&THISHREF=http://c.moreover.com/click/here.pl%3fz2534112361%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031273&HITNO=8&MSIZE=107&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ICS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031273&THISHREF=http://c.moreover.com/click/here.pl%3fz2534112361%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPacific Business News: Emerging Combination Agent from Merck Will Garner Peak Year Sales of More Than $250 Million for the Treatment of Asthmahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031265&HITNO=9&MSIZE=107&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ICS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031265&THISHREF=http://c.moreover.com/click/here.pl%3fz2534099283%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031265&HITNO=9&MSIZE=107&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ICS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031265&THISHREF=http://c.moreover.com/click/here.pl%3fz2534099283%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comWichita Business Journal: Emerging Combination Agent from Merck Will Garner Peak Year Sales of More Than $250 Million for the Treatment of Asthmahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031198&HITNO=10&MSIZE=107&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ICS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031198&THISHREF=http://c.moreover.com/click/here.pl%3fz2534057833%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031198&HITNO=10&MSIZE=107&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ICS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031198&THISHREF=http://c.moreover.com/click/here.pl%3fz2534057833%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBusiness First of Louisville: Emerging Combination Agent from Merck Will Garner Peak Year Sales of More Than $250 Million for the Treatment of Asthmahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031196&HITNO=11&MSIZE=107&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ICS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031196&THISHREF=http://c.moreover.com/click/here.pl%3fz2534057803%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031196&HITNO=11&MSIZE=107&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ICS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031196&THISHREF=http://c.moreover.com/click/here.pl%3fz2534057803%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNashville Business Journal: Emerging Combination Agent from Merck Will Garner Peak Year Sales of More Than $250 Million for the Treatment of Asthmahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031193&HITNO=12&MSIZE=107&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ICS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031193&THISHREF=http://c.moreover.com/click/here.pl%3fz2534053995%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031193&HITNO=12&MSIZE=107&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ICS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031193&THISHREF=http://c.moreover.com/click/here.pl%3fz2534053995%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comWashington Business Journal: Emerging Combination Agent from Merck Will Garner Peak Year Sales of More Than $250 Million for the Treatment of Asthmahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031094&HITNO=13&MSIZE=107&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ICS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031094&THISHREF=http://c.moreover.com/click/here.pl%3fz2533986272%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031094&HITNO=13&MSIZE=107&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ICS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031094&THISHREF=http://c.moreover.com/click/here.pl%3fz2533986272%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comHouston Business Journal: Emerging Combination Agent from Merck Will Garner Peak Year Sales of More Than $250 Million for the Treatment of Asthmahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031086&HITNO=14&MSIZE=107&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ICS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031086&THISHREF=http://c.moreover.com/click/here.pl%3fz2533984612%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031086&HITNO=14&MSIZE=107&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ICS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031086&THISHREF=http://c.moreover.com/click/here.pl%3fz2533984612%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBusiness Journal of Tampa Bay: